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SUMMARY
BubR1 insufficiency occurs with natural aging and
induces progeroid phenotypes in both mice and
children with mosaic variegated aneuploidy syn-
drome. In response to BubR1 insufficiency, skeletal
muscle, fat, and lens tissue engage p19Arf to atten-
uate senescence and age-related deterioration.
Here, we address how p19Arf exerts this caretaker
role using BubR1 progeroid mice lacking p53 or its
transcriptional target p21. We show that p53 delays
functional decline of skeletal muscle and fat in a
p21-dependent fashion by inhibiting p16Ink4a-medi-
ated senescence of progenitor cells. Strikingly, p53
also attenuates the formation of cataractous lenses,
but here its antiaging effect is p21 independent, as
we found p21 to promote senescence of lens epithe-
lial cells and cataract formation. Together, these
results demonstrate that p53 counteracts tissue
destruction in response to BubR1 insufficiency
through diverse mechanisms and uncover a causal
link between senescence of the progenitor cell
compartment and age-related dysfunction.
INTRODUCTION
Aging is a complex biological process that increases the risk of a
broad spectrum of human diseases and disorders, including
diabetes, osteoporosis, arthritis, cataracts, sarcopenia, and car-
diovascular and neurological disease (Campisi, 2005; Gau et al.,
2011; Lotz and Carame´s, 2011). Despite the importance of aging
to human health, the molecular mechanisms underlying the pro-
gressive physiologic decline with aging remain incompletely
understood (Marion et al., 2009). Studies in animal model sys-
tems have identified various genes that promote longevity
when mutated, including genes that encode components of
key metabolic pathways (Kenyon, 2010). Other efforts to
understand how we age focus on genes associated with human
progeria syndromes or mouse models that develop features
resembling accelerated aging (Burtner and Kennedy, 2010).
One of these genes encodes for BubR1, a core component of
the mitotic checkpoint that ensures accurate segregation of
chromosomes by participating in the inhibition of the ubiquitin
E3 ligase activity of Cdc20-activated anaphase-promoting
complex in the presence of unattached chromosomes (Baker
et al., 2004). Mutant mice carrying BubR1 hypomorphic alleles
(referred to as BubR1H/H mice) that produce low amounts of
the protein develop multiple progeroid and aging-associated
phenotypes, including short lifespan, dwarfism, facial dysmor-
phisms, cataracts, sarcopenia, (subdermal) fat loss, impaired
wound healing, and reduced dermal thickness (Baker et al.,
2004, 2008a; Hartman et al., 2007; Matsumoto et al., 2007).
Mutations in human BubR1 are associated with mosaic varie-
gated aneuploidy (MVA), a rare syndrome that is characterized
by aneuploidization and various progeroid traits, including short
lifespan, short stature, cataracts, facial dysmorphisms, and
mental retardation (Hanks et al., 2004; Lane et al., 2002; Mat-
suura et al., 2006; Suijkerbuijk et al., 2010). Several of these
age-associated features are observed in mice carrying a mono-
allelicBubR1MVAmutation (Wijshake et al., 2012). Furthermore,
BubR1 levels decrease with age in various mouse tissues and
sustained overexpression of BubR1 extends mouse healthspan
and lifespan, which has prompted speculation that BubR1might
be a determinant of chronological aging (Baker et al., 2004, 2013;
Hartman et al., 2007; Matsumoto et al., 2007).
p16Ink4a and p19Arf, two biomarkers of human and rodent
aging (Krishnamurthy et al., 2004), are selectively induced in
skeletal muscle, fat, and eye tissue of BubR1 progeroid mice
(Baker et al., 2008b). Genetic inactivation of p16Ink4a or clearance
of p16Ink4a-positive cells from BubR1 progeroid mice slows
functional decline of these tissues, demonstrating a causal link
between accumulation of senescent cells and functional impair-
ment in these tissues (Baker et al., 2008a, 2008b, 2011), although
the types of cells that are senescing have not been defined.
Inactivation of p19Arf, on the other hand, accelerates sarcopenia,
fat loss, and cataract formation, implying that its induction in
response to BubR1 insufficiency acts to suppress cellular stress
that drives cells into a senescent state (Baker et al., 2008b).
p19Arf accumulates in the nucleolus, where it binds NPM1 and
Mdm2 to suppress tumor development by inhibiting ribosome
biogenesis and initiating p53-dependent senescence and apo-
ptosis, respectively (Conboy et al., 2003; Conboy and Rando,
2002; Kamijo et al., 1997). The recent discovery of additional
binding partners has alluded to the existence of various p53-in-
dependent cellular functions of p19Arf (Conboy et al., 2003; Rio
Frio et al., 2010). The hypothesis that p19Arf might exert its anti-
progeroid effects in the context of BubR1 insufficiency through a
p53-dependent mechanism is directly challenged by studies on
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other progeroid mouse strains, such as Zmpste24 null (a model
for Hutchinson-Gilford progeria), Brca1 null, and Ercc1 hypo-
morphic mice, showing that p53 drives early aging in these
models (Cao et al., 2003; Kirkwood, 2002; Maier et al., 2004;
Nu´n˜ez et al., 2000; Sharpless, 2004; Tyner et al., 2002; Varela
et al., 2005).
Here, we further explored the molecular basis of MVA syn-
drome and the potential multifaceted role of p53 in premature
aging using p53-deficient BubR1 hypomorphic mice. p53 has
hundreds of potential downstream target genes implicated in a
wide variety of biological processes, including transient cell-
cycle arrest, cellular senescence, apoptosis, inhibition of angio-
genesis, autophagy, metabolism, and DNA repair (el-Deiry,
1998; Nakamura, 2004; Papazoglu and Mills, 2007). However,
the impact of individual p53 target genes on (accelerated) aging
remains largely unknown. We focused on the role of p21, a p53
target gene implicated in cell-cycle arrest and cellular senes-
cence (Cheung et al., 2012; Vousden and Prives, 2009), using
BubR1 hypomorphic mice that we bred onto a p21 null genetic
background. In addition to revealing that p53 is the critical medi-
ator of the p19Arf-induced antiaging responses in BubR1 proge-
roid mice, we identify p21 as the key downstream p53 target
gene through which the p53 protector function is executed in
two tissues: skeletal muscle and fat. Interestingly, we find that
insufficiency of BubR1 induces several senescence-associated
markers in progenitor cells residing in these tissues, not in
terminally differentiated cells. Senescence of these progenitors
is further elevated upon deletion of p21, demonstrating that
activation of p53 in BubR1 hypomorphic mice acts to mobilize
antiaging responses in adipose and skeletal muscle tissue.
Furthermore, we find that p21 induction in lens tissue promotes
cataract formation, but that p21-independent p53 responses
counteract this p21 effector function. These findings indicate
that BubR1 insufficiency elicits an aging response that is
counteracted by p53 and involves single or multiple p53 targets,
depending on the tissue type.
RESULTS
p53 and p21 Activation in BubR1H/H Mice Acts to Extend
Lifespan
p19Arf has several diverse functions, one of which is to stabilize
p53 through inhibition of Mdm2 (Conboy et al., 2003). Since
p53 has been linked to senescence and aging, we sought to
determine whether the p19Arf-dependent antiaging mechanism
activated in response to BubR1 insufficiency involves p53. As
a first step, we analyzed skeletal muscle, fat, and eye from
2-month-old BubR1H/H and wild-type mice for p53 protein levels
by western blot analysis. Previously, we documented that p19Arf
expression is markedly increased in these three tissues (Baker
et al., 2008b). Fat and eye extracts of BubR1H/H mice indeed
contained elevated levels of p53 protein (Figure 1A). We found
that the p53 target p21 was also elevated in these same tissues
(Figure 1A). Western blots of skeletal muscle extracts probed for
p53 and p21were inconclusive (data not shown), but quantitative
RT-PCR (qRT-PCR) analysis demonstrated that p21 gene tran-
script levels were significantly increased in skeletal muscle of
BubR1H/H mice (Figure 1B), suggesting that p19Arf induction
resulted in p53 stabilization in this tissue as well. BubR1H/H
tissues that developed age-related pathology in a p19Arf-inde-
pendent fashion (i.e., brain and aorta) or had no age-related
phenotypes (i.e., lung, pancreas, and colon) did not exhibit
increased expression of p21 (Figure S1). Thus, p53 and p21
appear to be selectively induced in p19Arf-positive BubR1H/H tis-
sues subjected to premature aging.
To determine the role of p53 and p21 in the p19Arf-dependent
antiaging mechanism activated in response to BubR1 insuffi-
ciency, we bred BubR1H/H mice onto a p53 (Jacks et al., 1994)
or p21 (Brugarolas et al., 1995) homozygous null genetic back-
ground. Cohorts of BubR1H/H, p53/, and p21/ mice were
used as controls. All cohorts were monitored for the develop-
ment of age-related phenotypes for a period of up to 1 year.
Ablation of p53 or p21 dramatically shortened the median overall
survival of BubR1H/H mice by 35% (Figure 1C). Additionally, the
maximum lifespan of BubR1H/H;p53/ or BubR1H/H;p21/
mice was significantly decreased compared to BubR1H/H mice
(Figure 1C). The tumor incidence of BubR1H/H;p53/ mice
was low compared to that of p53/ mice, with 17% of
BubR1H/H;p53/ mice having tumors compared to 96% of
p53/ mice (Figure 1D). Although the overall tumor latency
(thymic lymphoma and osteosarcoma) was similar forBubR1H/H;
p53/ and p53/ mice (Figure 1E), the latency of osteosar-
coma of BubR1H/H;p53/ mice was significantly decreased,
indicating that BubR1 insufficiency accelerates sarcoma forma-
tion in the absence of p53 (Figure 1D). No tumors were observed
upon postmortem examination of BubR1H/H;p21/ mice (Fig-
ure 1D). These data reveal that the substantial reduction in life-
span of BubR1 hypomorphic animals lacking p53 or p21 cannot
be explained by accelerated tumorigenesis.
p53 Acts through p21 to Delay Progeroid Decline
in Muscle and Fat
Inactivation of p19Arf accelerates sarcopenia, fat loss, and cata-
ract formation inBubR1H/Hmice. If p53 and p21 inactivation phe-
nocopy the effects of p19Arf depletion, this would indicate that
p53 would be the critical target of p19Arf, and p21 that of p53.
Consistent with this, we found that lordokyphosis (an abnormal
rearward curvature of spine), a phenotype that in BubR1H/H
mice is caused by sarcopenia (Baker et al., 2004), was signifi-
cantly accelerated in both BubR1H/H;p53/ and BubR1H/H;
p21/mice (Figure 2A). Gastrocnemius and abdominal muscles
of 6-week-oldBubR1H/H;p53/ andBubR1H/H;p21/mice had
significantly smaller fibers than those of BubR1H/H mice (Fig-
ure 2B), confirming that sarcopenia was indeed accelerated
following the loss of p53 or p21. Lordokyphosis did not develop
in p53/ and p21/ mice during the 1 year observation period
(data not shown). Skinning of 6-week-old mice demonstrated
that adipose tissue deposits of BubR1H/H;p53/ and BubR1H/H;
p21/ mice were overtly smaller than those of BubR1H/H mice
(Figure 2C). The weight of the inguinal adipose tissue (IAT) re-
vealed that this fat depot was significantly reduced (Figure 2D).
Consistent with reduced fat and muscle volume, BubR1H/H;
p53/ and BubR1H/H;p21/ mice had significantly lower
body weights than BubR1H/H mice (Figure 2D). The progeroid
phenotypes of dermal thinning and arterial wall stiffening were
not exacerbated following the loss of p53 or p21 (Figures S2A
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and S2B), which is consistent with the finding that p21 levels are
not elevated in dermis and aorta of BubR1H/H mice (Figure S1).
Collectively, these data provide evidence that induction of p21
through p19Arf-dependent stabilization of p53 counteracts
Figure 1. p53 Promotes Longevity in BubR1
Hypomorphic Mice through p21
(A) Western blots of eye and adipose tissue ex-
tracts from 2-month-old wild-type and BubR1H/H
mice probed with p21 and p53 antibodies. Tubulin
antibody served as a loading control.
(B) qRT-PCR analysis of gastrocnemius muscles
from 2-month-old mice analyzed for p21 expres-
sion. n = 5 mice of each genotype ±SD.
(C) Kaplan-Meier overall survival curves of the
indicated mice. Asterisks denote significance
compared to BubR1H/H mice using log-rank tests.
The maximum lifespan of BubR1H/H;p53/ and
BubR1H/H;p21/ mice was significantly short-
ened compared toBubR1H/H mice (p = 0.0226 and
p = 0.0034, respectively; two-sided Wang/Allison
test referring to the proportion of mice alive at the
90th percentile survival point).
(D) Tumor incidence and latency of mice indicated
in (C). The time to osteosarcoma formation in
BubR1H/H;p53/ mice is significantly faster than
in p53/ mice.
(E) Tumor-free survival curves of mice dying of
cancer from (C). TheBubR1H/H;p53/ and p53/
curves are both significantly different from
BubR1H/H (log-rank test). No BubR1H/H;p21/ or
p21/ mice died of tumors over the duration of
the experiment.
*p < 0.05; **p < 0.01; ***p < 0.001. See also Figures
S1 and S2.
aging-associated functional decline of
skeletal muscle and fat tissue in response
to BubR1 insufficiency.
p21 Inhibits Degeneration of
Skeletal Muscle and Fat by
Preventing Senescence
To provide insight into the mechanism by
which p21 inactivation promotes func-
tional decline of skeletal muscle and fat
tissue of BubR1 hypomorphic mice, we
asked if loss of p53 or p21 acts to pro-
mote cellular senescence, a process
that has been linked to age-related
pathologies in this model (Baker et al.,
2008b, 2011). Fat of 5-month-old prema-
turely aged BubR1H/H mice is known to
express high amounts of senescence-
associated b-galactosidase (SA-b-gal),
an established marker for the detection
of senescent cells in cell culture and
select mouse tissues (Baker et al.,
2008b, 2011). Adipose tissue of
BubR1H/H mice showed relatively low
SA-b-gal activity at 6 weeks of age. In
contrast, fat of BubR1H/H;p53/ and BubR1H/H;p21/ mice
showed high SA-b-gal activity at this age (Figure 3A), indicating
increased senescence. In keeping with this, other markers of
cellular senescence in fat were also markedly elevated, including
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p16Ink4a, p19Arf, Pai1, Igfbp2, and IL-6 (Baker et al., 2008b, 2011;
Krishnamurthy et al., 2004) (Figure 3B). Similarly, markers of
skeletal muscle senescence, such as p16Ink4a, p19Arf, Igfbp2,
Mmp13, and Nrg1 (Baker et al., 2008b), were all elevated in
BubR1H/H muscles compared to wild-type muscles, and even
more in BubR1H/H;p53/ and BubR1H/H;p21/ muscles (Fig-
ure 3C). Cell proliferation, as measured using in vivo BrdU incor-
poration, was considerably lower in both adipose tissue and
skeletal muscle of BubR1H/H;p53/ and BubR1H/H;p21/
mice than in BubR1H/H mice (Figure 3D), further supporting the
notion that rates of senescence were increased in these tissues.
In accordance with previous observations (Baker et al., 2004,
2008a), the premature aging of these tissues is not associated
with increased DNA damage (Figures S2C and S2D). We note
that the attenuating effect of p53 or p21 on in vivo senescence
in BubR1H/H mice cannot be recapitulated in vitro using cultured
BubR1H/H mouse embryonic fibroblasts (MEFs), most likely
because these cells immortalize when p53 or p21 is lacking (Fig-
ures S2E–S2H). Collectively, the above data suggest that p53-
mediated activation of p21 in response to BubR1 insufficiency
acts to preserve skeletal muscle and adipose tissue integrity
Figure 2. p53 Exerts its Antiaging Effects in
Skeletal Muscle and Fat of BubR1H/H Mice
through p21
(A) Incidence and latency of lordokyphosis in mice
of the indicated genotypes.
(B) Average muscle fiber size of gastrocnemius and
abdominal muscles of 6-week-old mice.
(C) Skinned 6-week-old BubR1H/H, BubR1H/H;
p53/, and BubR1H/H;p21/ mice. Note the pro-
found lordokyphosis (black dotted line) and the
markedly reduced adipose depots in the BubR1
progeroid mice lacking p53 or p21 (yellow arrows
and hashed area). Scale bar represents 1 cm.
(D) IAT (left) and body weight (right) are both
reduced when p53 or p21 is lost from 6-week-old
BubR1 hypomorphic mice.
Data in (B) and (D) are mean ±SD (n = 5 mice per
genotype). Asterisks denote significant changes
from BubR1H/H values. **p < 0.01; ***p < 0.001. See
also Figures S1 and S2.
by driving cells into a state of reversible
temporal cell-cycle arrest that protects
against entry into a senescent state.
p21 Attenuates Progenitor Cell
Senescence in Muscle and Fat of
BubR1H/H Mice
Although accumulation of senescent cells
in skeletal muscle and fat of BubR1H/H
mice has been causally implicated in tis-
sue dysfunction, the types of cells in these
tissues that are subject to senescence
were unknown. To address these key
open questions, IAT collected from
5-month-old BubR1H/H mice was stained
for SA-b-gal, squeezed between two
microscopy slides, and analyzed by light
microscopy. While mature adipocytes were negative for SA-
b-gal, areas that appeared to track with the fat tissue vasculature
were frequently positive (Figure 4A). These areas include endo-
thelial cells, white blood cells, adipocyte stem cells (ASCs),
and preadipocytes (PACs), collectively termed the stromal
vascular fraction (SVF) (Cawthorn et al., 2012). To determine
which cells of the SVF were prone to senescence, we prepared
single cells from IAT using collagenase treatment and a combi-
nation of centrifugation and fluorescence-activated cell sorting
to collect mature adipocytes, endothelial cells, and a combined
population of ASCs and PACs (Figure S3A). As expected, mature
adipocytes stained negative for SA-b-gal, whereas the SVF was
highly positive (Figure S3B). Strikingly, the relative number of
ASCs/PACs in the SVF of 2-month-old BubR1H/H mice was
about 3-fold lower than in wild-type mice (Figure 4B). Compared
to wild-type mice, p16Ink4a transcript levels were highly elevated
in the ASC/PAC cell fraction of BubR1H/H mice, but not in adipo-
cytes and endothelial cells (Figure 4C). Other markers of cellular
senescence were also markedly elevated in this fraction (Fig-
ure 4D), indicating that fat progenitor cells with low amounts of
BubR1 are prone to become senescent.
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Senescent cells in skeletal muscle of BubR1H/H mice do not
visibly stain the tissue for SA-b-gal activity (data not shown),
precluding microscopy as a means to provide insight into the
kinds of cells in this tissue that are prone to senescence. In an
alternative approach outlined in Figure S3C, we used collage-
nase treatment of skeletal muscle from 2-month-old BubR1H/H
mice followed by purification of muscle fibers and particular
populations of mononuclear cells, including quiescent satellite
cells (Q-SCs; muscle stem cells) and fibro/adipogenic progeni-
tors (FAPs; a subpopulation of mononuclear cells that does not
generate myofibers but facilitate myogenesis; Joe et al., 2010).
Mature skeletal muscle fibers from BubR1H/H mice exhibited
no significant increase in p16Ink4a transcripts (Figure 5A), nor
did Q-SCs from these mice. In contrast, the FAP pool of
BubR1H/H cells had very high p16Ink4a transcript levels compared
to their counterparts from wild-type mice (Figure 5A). Several
additional markers of senescence in skeletal muscle were
elevated in the FAP population (Figure 5B), indicating that
progenitor cells with insufficient amounts of BubR1 are prone
to senesce.
We next collected ASC/PAC and FAP populations from
BubR1H/H;p21/ mice to examine whether accelerated aging
in the skeletal muscle and fat of these animals correlates
with increased progenitor cell senescence. All markers of
senescence were significantly higher in ASCs/PACs from
BubR1H/H;p21/ mice than from BubR1H/H (Figure 4D). FAP
populations also exhibited an even further elevation in senes-
cence markers upon loss of p21 in BubR1H/H (Figure 5B).
Importantly, consistent with impaired function of FAPs, repair
Figure 3. p53-Mediated Induction of p21
Attenuates Senescence in BubR1H/H Skeletal
Muscle and fat
(A) IAT of 2-month-old BubR1H/H, BubR1H/H;p53/
and BubR1H/H;p21/ mice stained for SA-b-gal
activity. Scale bar, 5 mm.
(B and C) qRT-PCR analysis of senescence marker
expression in IAT (B) and gastrocnemius muscles
(C) of 2-month-old BubR1H/H, BubR1H/H;p53/
and BubR1H/H;p21/ mice relative to wild-type
mice. Values were normalized against wild-type
values.
(D) Cell proliferation rates in adipose tissue and
skeletal muscle of 2-month-old male mice analyzed
by in vivo BrdU incorporation as a measure for
in vivo senescence. ABD, abdominal muscle; PARA,
paraspinal muscle.
Data in (B)–(D) are mean ±SD (n = 5 mice per
genotype). Asterisks denote significant changes
from BubR1H/H values. **p < 0.01. See also
Figure S2.
of cardiotoxin-induced damage of
skeletal muscle tissue was already
markedly impaired in BubR1H/H;p53/
and BubR1H/H;p21/ mice at a very
young age (Figure 5C). Together, these
data suggest that p21, through p53 acti-
vation, acts to protect progenitor cells
from senescence due to BubR1 insufficiency in adipose and
skeletal muscle tissue.
p53 Inhibits Cataractogenesis in BubR1H/H Mice via a
p21-Independent Mechanism
A prominent aging-related feature of BubR1 hypomorphic mice
is the development of cataracts (Baker et al., 2004), a phenotype
that is significantly accelerated following the loss of p19Arf (Baker
et al., 2008b). We found that ablation of p53 accelerated cataract
formation in BubR1H/H mice (Figure 6A), which suggested that
p19Arf-mediated induction of p53 delayed age-related deteriora-
tion of lens tissue in a manner similar to that observed in skeletal
muscle and fat. However, unlike in skeletal muscle and fat, the
p53-dependent protective mechanism in lens was p21 indepen-
dent, as genetic inactivation of p21 in BubR1H/H mice resulted in
delayed rather than exaggerated cataract formation (Figure 6A).
To examine the potential mechanisms underlying these con-
trasting observations, we performed a histological assessment
on lenses of 2-month-old wild-type, BubR1H/H, BubR1H/H;
p53/, and BubR1H/H;p21/ mice. As previously documented
(Baker et al., 2004), 2-month-old BubR1H/H mice show signs of
early cataract formation, with lens epithelial cells and Morgag-
nian globules accumulating at the posterior part of the lens
(Figures 6B and 6C). In BubR1H/H;p53/ mice, these two path-
ological features were substantially worsened, which closely
correlated with the earlier onset of cataracts in these animals.
On the other hand, epithelial cells in the posterior of the lens
were significantly reduced in BubR1H/H;p21/ mice and Mor-
gagnian globules were rarely detected. Recent findings using
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an INK-ATTAC transgenic construct that allows for clearance of
p16Ink4a-positive senescent cells have shown that these cells are
causally implicated in cataract formation in BubR1H/H mice
(Baker et al., 2011). Consistent with an accelerated rate of senes-
cence-dependent cataract formation, p16Ink4a transcript levels
in eyes of 6-week-old BubR1H/H;p53/ mice were significantly
higher than those eyes of age-matched BubR1H/H mice (Fig-
ure 6D). A very similar increase was observed for the senescent
cell marker p19Arf (Figure 6D). Furthermore, in accordance with
decreased cataract formation due to prevention of cellular
senescence, eyes of BubR1H/H;p21/ mice had significantly
lower p16Ink4a and p19Arf transcript levels than eyes of
BubR1H/H mice (Figure 6D). Collectively, these data provide
evidence for a tissue in which p53 acts both as an effector and
an attenuator of age-related deterioration through engagement
of p21-dependent and p21-independent mechanisms, respec-
tively. We found that transcript levels of multiple effectors of
p53-mediated apoptosis were significantly elevated in catarac-
tous lenses of BubR1H/H (Figure 6E), suggesting that apoptosis
is a key p21-independent mechanism through which p53 atten-
uates cataractogenesis in BubR1H/H mice.
DISCUSSION
p19Arf expression markedly increases with age in various human
and rodent tissues (Krishnamurthy et al., 2004), but whether and
how this tumor suppressor influences aging-related processes
remains unclear. A key barrier has been the fact that p19Arf
knockout mice die of cancer before they develop age-related
pathologies (Kamijo et al., 1997). In a previous study, we by-
passed this problem by studying the impact of p19Arf disruption
in BubR1 progeroidmice, which revealed that p19Arf protects the
skeletal muscle, adipose tissue, and eye of these mice against
aging-related deterioration (Baker et al., 2008b). Here, we used
a genetic approach involving p53 and p21 knockout mice to
dissect the molecular mechanisms underlying this protective
effect, which led to four significant insights.
First, our observation that BubR1H/H;p53/ mice phenocopy
BubR1H/H;p19Arf/ mice demonstrates that p53 is the key crit-
ical downstream target of p19Arf. In turn, our discovery that the
skeletal muscle and fat phenotypes of BubR1H/H;p21/ mice
mimic those of BubR1H/H;p53/ mice reveals that p21 is the
relevant target of p53 in these tissues. Both of these findings
are remarkable given that p19Arf has amyriad of binding partners
implicated in diverse biological processes (Conboy et al., 2003)
and that p53 has hundreds of potential transcriptional targets
as well as a growing number of nontranscriptional functions
(Vousden and Prives, 2009).
Second, it has been reported that p21 drives cellular senes-
cence and age-related pathology in a progeroid mouse model
for telomere dysfunction (Choudhury et al., 2007). Our finding
here that p21 loss accelerates skeletal muscle and fat deteriora-
tion in BubR1 progeroidmice uncovers a role for p21 as an atten-
uator of age-related decline. We show that engagement of p21 in
these tissues reduces formation of p16Ink4a-positive senescent
cells, suggesting that p21-mediated temporary cell-cycle arrest
or quiescence helps relieve the stress or damage that stimulates
the p16Ink4a-Rb pathway to establish the senescent phenotype.
Studies in cultured cells revealed that p21-independent p53
activities, including p53-mediated inhibition of the mTOR path-
way, counteract p21-mediated cellular senescence (Minagawa
et al., 2011). However, in the context of BubR1 insufficiency,
the senescence suppressive effect seems entirely p21 depen-
dent because p21 and p53 loss phenocopy each other in most
tissues. In preliminary studies, BubR1 progeroid mice fed a
diet containing the mTOR inhibitor rapamycin developed age-
related phenotypes at similar rates as mice on a control diet
(T.W. and J.v.D., unpublished data), which is consistent with
Figure 4. Fat Progenitor Cells of BubR1
Hypomorphic Mice Are Senescence Prone
(A) SA-b-gal-positive cells from IAT accumulate in
regions that track along blood vessels (red dotted
line) and not in mature adipocytes of 5-month-old
BubR1H/H mice. Scale bars represent 1 mm (left)
and 100 mm (right).
(B) Quantitation of ASCs/PACs in IAT of 2-month-
old mice. Values are expressed as percent of
Sca1+ cell numbers to account for differences in
input material among genotypes.
(C) qRT-PCR analysis for p16Ink4a expression in
sorted adipose cells from 2-month-old wild-type
and BubR1H/H mice. Values are normalized to wild-
type endothelial cells (Endo). AC, adipocyte.
(D) qRT-PCR analysis for senescence marker
expression in ASCs/PACs from 2-month-old mice
relative to wild-type cells.
Data in (B)–(D) are mean ±SD (n = 3 mice per
genotype). Asterisks denote significant changes
from BubR1H/H values. *p < 0.05; **p < 0.01. See
also Figure S3.
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the notion that p21-mediated protection of skeletal muscle and
fat against progeroid decline does not involve p21-independent
activities of p53.
Third, the observation that disruption of p21 in BubR1 proge-
roid mice attenuates cataract formation provides evidence that
p21 can also act as an effector of age-related deterioration in
response to BubR1 insufficiency in a tissue-selective manner
(Figure S4). The most straightforward explanation would be
that the extent or duration of p21 engagement in lens epithelial
cells reaches a threshold for activation of the senescence pro-
gram, but not in skeletal muscle and fat. Intriguingly, in contrast
to loss of p21, loss of p53 accelerates cataract formation in
BubR1 progeroid mice, characterizing p53 as a protector of
age-related decline of lens tissue (Figure S4). A possible expla-
nation for these contrasting effects would be that p21-indepen-
dent functions of p53 induce apoptosis of damaged cells,
thereby preventing the accumulation of cells in the posterior
part of the lens where they are able to distort its integrity. This
possibility is supported by the observation that several p53
target genes thatmediate apoptosis are induced in lens epithelial
cells in response to BubR1 insufficiency (Figure 6E). It is impor-
tant to note that p53 has multiple activities other than mediating
senescence and apoptosis (Vousden and Prives, 2009). Perhaps
one or more of these activities may act to facilitate proper termi-
nal differentiation of lens epithelial cells from BubR1 progeroid
mice, which would also reduce the incidence of aberrant migra-
tion of lens epithelial cells to posterior part of the lens (Figure S4).
Fourth, the cell types within skeletal muscle and fat of BubR1
hypomorphic mice that undergo senescence to drive progeroid
tissue dysfunction were unknown. Here, we provide evidence
to suggest that progenitor cells in both these tissues are highly
prone to cellular senescence. We propose that the acquisition
of senescence in these cell populations may contribute to aging
of the tissue through two distinct mechanisms. First, senescence
acts to reduce the number of progenitors capable of undergoing
the remaining steps to terminal differentiation to replenish or
repair tissue. Second, these senescent progenitors may pro-
mote further dysfunction of neighboring progenitor and stem
cells by affecting the niche where these cells reside through
the senescence-associated secretory phenotype (SASP) that
senescent cells acquire. The finding that deletion of p21
increases senescence marker levels in progenitor populations
of BubR1 hypomorphic mice suggests that p21 engagement
ameliorates senescence-causing stress resulting from BubR1
insufficiency in these cells. One possibility is that these
highly mitotic populations engage p21 as a molecular switch to
remain in the cell cycle, rather than permanently withdrawing
and producing a SASP. Earlier, we documented that the attenu-
ating effect of p19Arf ablation on in vivo senescence in skeletal
muscle and fat of BubR1H/H mice is not recapitulated by the
effect on in vitro senescence in BubR1H/H MEFs (Baker et al.,
2008b). We find that the same holds true for ablation of p53 or
p21 (Figures S2E–S2H), underscoring that the endogenous cell
signaling circuitry dictating cell fate is complex and difficult to
mimic in vitro. To further advance the idea that p21 might serve
as a molecular switch between senescence and transient
cell-cycle arrest in response to BubR1-induced cellular stress,
it will therefore be important to develop mouse models in which
p21 can be deleted in a tissue-specific and temporally control-
lable fashion.
Our identification of p53 as a protector against aging-related
pathology in BubR1 insufficient mice contrasts studies of other
progeroid models, which have characterized p53 as an effector
of functional decline (Kirkwood, 2002; Sharpless, 2004; Vousden
and Lane, 2007). How can these divergent roles of p53 be recon-
ciled? Whether p53 signaling in response to DNA damage
induces apoptosis, cellular senescence, or cell-cycle arrest is
highly dependent on the cell or tissue type and the nature and
extent of damage (Vousden and Prives, 2009). Likewise, the
various stresses implicated in the distinct progeroid models
could differentially engage p53. It is conceivable that progeroid
models in which p53 loss delays tissue deterioration can induce
Figure 5. p21 Counteracts Progenitor Cell
Senescence and Promotes Tissue Regener-
ation in BubR1H/H Skeletal Muscle
(A) qRT-PCR analysis for p16Ink4a expression in
sorted cells from gastrocnemius muscle of
2-month-old wild-type andBubR1H/Hmice. Values
are normalized to wild-type Q-SCs.
(B) qRT-PCR analysis for senescence marker
expression in FAPs from 2-month-old gastrocne-
mius muscle. Expression is relative to wild-type
cells.
(C) Gastrocnemius muscles of 2-month-old
animals on day 18 after cardiotoxin injection. Note
the centralized nuclei present in the myofibers of
wild-type and BubR1H/H muscle, indicative of
restoration of muscle architecture. In contrast,
BubR1H/H;p53/ and BubR1H/H;p21/ animals
have been unable to restore normal structure and
still exhibit a profound hypercellular response.
Scale bar represents 100 mm.
Data in (A) and (B) are mean ±SD (n = 3 mice per
genotype). Asterisks denote significant changes
from BubR1H/H values. *p < 0.05; **p < 0.01; ***p <
0.001. See also Figure S3.
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a robust p53 transcriptional response that leads to apoptosis or
senescence, leading to tissue degeneration and aging. In our
model, perhaps a lower chronic triggering of the p53 pathway
may avoid these potentially negative effects of cell death or
senescence. Progeroid models in which p53 inactivation attenu-
ates premature aging involve age-related features distinct from
BubR1 mutant mice, raising the possibility that the tissues sub-
jected to cellular stress are distinct, which could underlie differ-
ential consequences of p53 activation.
What might be the potential significance of our findings to
natural aging? Early studies involving mutant mouse strains ex-
pressing p53 isoforms introduced the concept that p53 hyperac-
Figure 6. p53 Delays while p21 Drives Cata-
ractogenesis in BubR1 Progeroid Mice
(A) Incidence and latency of cataract formation
in BubR1H/H, BubR1H/H;p53/, and BubR1H/H;
p21/ animals as detected by use of slit light after
dilating the eyes.
(B) Hematoxylin and eosin-stained lenses of
2-month-old mice. Arrowheads indicate posteri-
orly located lens epithelial cells. Asterisks mark
Morgagnian globules. Scale bar represents
100 mm.
(C) Quantitation of the average number of poste-
riorly located cells (defined as cells that have
migrated past the lens epithelial bow) in lenses of
the indicated genotypes. Data are mean ±SD
(n = 4 mice per genotype, two lenses per mouse).
We note that no cells are detectable in this area of
wild-type mice.
(D) qRT-PCR analysis of p16Ink4a and p19Arf
expression in eye tissue of 2-month-old mice.
Data are mean ±SD (n = 5 mice of each genotype).
(E) qRT-PCR analysis on lens tissue of 6-month-
old wild-type and BubR1H/H mice. Data are
mean ±SD (n = 10 mice per genotype).
Asterisks denote significant differences compared
to BubR1H/H mice. *p < 0.05; **p < 0.01; ***p <
0.001. See also Figure S4.
tivity drives the aging process (Maier
et al., 2004; Tyner et al., 2002). The finding
that p19Arf levels increase in many human
and rodent tissues further supported this
idea (Krishnamurthy et al., 2004). How-
ever, studies in normalmice subsequently
suggested that p53 function actually de-
clines with aging (Feng et al., 2007).
This, together with the finding that trans-
genic mice containing an extra copy of
wild-type endogenous p53 and p19Arf
have an increased healthspan and life-
span (Matheu et al., 2007), has called
the proaging effect of p53 into question.
Our data provide in vivo support for the
emerging concept that the p19Arf-p53
pathway plays an important role in pro-
tection against functional decline of select
tissues and organs during natural aging. It
will now be important to further test this concept in naturally aged
wild-typemice. It should be noted that the progeroid model used
in this study may be much more relevant to normal aging than
previously anticipated. In normal mice, BubR1 levels decline
with aging in various tissues, with late-life BubR1 protein levels
in normal mice reaching levels similar to those in BubR1H/H
mice at an early age (Baker et al., 2004;Hartman et al., 2007;Mat-
sumoto et al., 2007). Preventing this decline by sustained high
overexpression of transgenic BubR1 has recently been shown
to increase lifespan and healthspan of mice (Baker et al., 2013).
Interestingly, attenuated sarcopenia in these mice is coupled
with a delayed induction of both p16Ink4a and p19Arf.
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EXPERIMENTAL PROCEDURES
Mouse Strains and MEFs
BubR1H/H mice were generated as previously described (Baker et al., 2004).
p53 (Jacks et al., 1994) and p21 (Brugarolas et al., 1995) knockout mice
were acquired from The Jackson Laboratory (Bar Harbor, ME, USA). These
mice were bred to BubR1+/H mice, and the resulting double-heterozygous
mice were intercrossed to generate wild-type, BubR1H/H, BubR1H/H;p21/,
p21/, BubR1H/H;p53/, and p53/ mice. Similar crosses were used to
generate MEFs as previously described (Baker et al., 2008b). MEFs were
generated from trypsinized carcasses of 13.5-day-old embryos as previously
described (Babu et al., 2003). MEFs were cultured at 3% oxygen for two
passages and then switched to 20% oxygen and used for experimentation
at subsequent passages. All mice were on a mixed 129 3 C57BL/6 genetic
background. Animals were housed in a pathogen-free barrier environment
for the duration of the study. Experimental procedures involving the use of
laboratory mice were reviewed and approved by the Mayo Clinic Rochester
Institutional Animal Care and Use Committee.
Western Blot Analyses
Western blot analyses were carried out as previously described (Kasper et al.,
1999). Equal loading was determined using tubulin as previously described
(Baker et al., 2008b). Antibodies for senescence-associated proteins were
as previously described (Baker et al., 2004, 2006). Western blotting for
gH2AX of 2-month-tissues was performed as previously described (Baker
et al., 2008a) with Ponceau S to equalize protein loading.
Analysis of Progeroid Phenotypes
Biweekly checks for lordokyphosis and cataracts were as previously
described (Baker et al., 2008b). Skeletal muscle fiber diameter measure-
ments were performed on cross-sections of gastrocnemius and abdominal
muscles of 6-week-old male mice (n = 5 per genotype). A total of 50 fibers
per sample were measured using a calibrated computer program (Olympus
MicroSuite Five). Aorta thickness measurements were performed on cross-
sections of paraffin-embedded aorta isolated from 2-month-old male mice
(n = 5 per genotype), and 50 random-thickness measurements were taken
as described above. Dissection, histology, and measurements of dermal
and adipose layers of dorsal skin were performed as described previously
(Baker et al., 2004). Measurements of body weight and IAT were performed
on 6-week-old males (n = 5 per genotype). For analysis of cataract forma-
tion, 2-month-old eye tissue was embedded and sectioned through the
middle of the lens. The number of cells that had migrated past the lens
epithelial bow was counted (n = 8 lenses per genotype). Cardiotoxin treat-
ment was performed on 2-month-old mice as previously described (Baker
et al., 2008b).
qRT-PCR
qRT-PCR was performed as described on inguinal adipose tissue, skeletal
muscle, and total eye tissue (Baker et al., 2008b). Lens tissue was isolated
from 6-month-old mice by first removing the cornea. Both lenses of the
same animal were used for RNA extraction as previously described (Baker
et al., 2008b). Sequences of primers for p16Ink4a, p19Arf, p21, Pai1, Igfbp2,
IL-6, Mmp13, and Nrg1 used were as published elsewhere (Baker et al.,
2011). Additionally, the following primer pairs were used: Puma: forward
50-CGGACGGTCCTCAGCCCTCCCT-30, reverse 50-GCTCTTCTTGTCTCCG
CCGCTCG-30; Noxa: forward 50-GGTGCCAGCAGACTTGAAGGACG-30,
reverse 50-CCAATACCAGGCATTTCCATCAACC-30; Bid: forward 50-AATA
GAGCCAGATTCTGAAAGTCAG-30, reverse 50-GCAGTTCCTTTTGTCTTCC
TCCG-30; Bax: forward 50-GCTTGGGAGCGGCGGGCCCACC-30, reverse
50-CGATCCTGGATGAAACCCTGTAGC-30.
In Vivo BrdU Incorporation and SA-b-Gal Staining
Analyses for in vivo BrdU incorporation were performed as previously
described (Baker et al., 2008b). Adipose tissue deposits were stained for
SA-b-gal activity as previously described (Baker et al., 2004). MEF growth
rates and senescence staining was performed as previously described (Baker
et al., 2008b).
Single-Cell Isolation, Labeling, and Collection
Preparation of single cells from inguinal adipose tissue (Baker et al., 2011) and
gastrocnemius muscle (Baker et al., 2013) were as previously described. ASC,
PAC, and endothelial cells were isolated from adipose tissue cell suspensions
using well-documented cell-type-specific cell surface markers (Cawthorn
et al., 2012). To determine the number of ASC and PAC, the total number of
CD34+;Sca1+ cells was divided by the number of Sca-1+ cells. Labeling and
isolation of Q-SCs and FAPs was performed as described elsewhere (Joe
et al., 2010). Skeletal muscle fibers were retrieved from the filter used to collect
single cells after collagenase treatment. All antibodies (BD Bioscience) were
used at a 1:100 dilution.
Statistical Analysis
GraphPad Prism software was used for the generation of all survival curves
and for statistical analyses. Log-rank tests were used to determine overall
and pairwise significance in Figures 1C, 1E, 2A, and 6A. Two-sided Wang-
Allison tests were used to determine maximum lifespan changes (Wang
et al., 2004) in Figure 1C. Mann-Whitney tests were used for significance
in Figures 1B, 1D, 2B, 2D, 3B–3D, 6D and in Figures S1, S2A, and S2B.
An unpaired t test was used for significance in Figures 4B–4D, 5A, 5B, 6C,
and 6E and in Figures S2E and S2F. For consistency in these analyses,
the significance of values is defined as follows: *p < 0.05, **p < 0.01, and
***p < 0.001.
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